Mirum Pharmaceuticals, Inc. (MIRM) vs Scholar Rock Holding Corporation (SRRK)

A side-by-side comparison of Mirum Pharmaceuticals, Inc. and Scholar Rock Holding Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — MIRM vs SRRK

growth of $100 · dividends reinvested · last 7y
MIRM +516.4% (+29.7%/yr)SRRK +216.8% (+17.9%/yr)MIRM compounded faster over this window
02004006008001kStart $100202120232025$616$317
MIRM SRRK

MIRM vs SRRK: by the numbers

  • •SRRK is the larger company ($5.09B vs $4.83B market cap).
  • •Both run net losses; SRRK's is the smaller (0.00% vs -139.18% net margin).

Metrics side by side

Valuation

MetricMIRMSRRK
P/S ratio7.82N/A
P/B ratioN/A20.04

Profitability

MetricMIRMSRRK
Gross margin81.70%0.00%
Operating margin-4.25%0.00%
Net margin-139.18%0.00%
ROEN/A-161.00%
ROIC-13.09%-90.04%

Growth (annualized)

MetricMIRMSRRK
Revenue CAGR (5Y)123.86%N/A
Total return CAGR (5Y)37.24%8.20%

Frequently asked

How have MIRM and SRRK total returns compared?
Over the past 5 years, MIRM delivered 37.24% and SRRK delivered 8.20% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.